Dura Biotech
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
3
INVESTORS
Description
Developer of technologies designed to improve the functionality and durability of bioprosthetic valves. The company's technologies include the transcatheter valve replacement/repair systems and a pre-operative planning software of transcatheter valve intervention, enabling clinicians to avail durable and elegant services to treat complex diseases and ultimately improve patients' lives.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Primary Office
- 20A Pasco Drive
- East Windsor, CT 06088
- United States
+1 (860) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Dura Biotech’s full profile, request a free trial.
Dura Biotech Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 01-Aug-2018 | Completed | Generating Revenue | |||
| 3. Grant | 15-Jul-2016 | 00000 | Completed | Generating Revenue | ||
| 2. Grant | 30-Dec-2014 | $2M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Apr-2013 | Completed | Generating Revenue |
Dura Biotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | |||
| Connecticut Innovations | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| The University of Connecticut's Technology Incubation Program | Accelerator/Incubator | 000 0000 | 000000 0 |
Dura Biotech Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Isa Risk | Chief Executive Officer | ||
| Thuy Pham | Co-Founder & Chief Technology Officer | ||
| Wei Sun | Co-Founder & Scientific Advisor |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »